Despite New Rare Pediatric Disease Designation Catalyst Biosciences Inc. (CBIO) Continues to Slide
Gule Rukhsar
January 26, 2022
On January 25, 2022, Catalyst Biosciences Inc. (CBIO) notified the reception of Rare Pediatric Disease Designation (RPDD) for CB 4332 for CFID treatment. Unaffected by